| Filed On | Filing |
|---|---|
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
SAN FRANCISCO, Calif., November 5, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 second quarter ended September 30, 2026. |
| 02 Sep 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On August 27, 2026, Doximity, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the three proposals outlined in the Company’s definitive p... |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
SAN FRANCISCO, Calif., August 6, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 first quarter ended June 30, 2026. |
| 13 May 2026 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
Fiscal year 2026 total revenues of $644.9 million, up 13% year-over-year |
| 17 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
As previously disclosed by Doximity, Inc. (the “Company”) on February 5, 2026, Anna Bryson, the Company’s Chief Financial Officer, had been on medical leave. On April 13, 2026, the Company accepted her resignation as Chief Financial Offi... |
| 05 Feb 2026 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
SAN FRANCISCO, Calif., February 5, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 2025. |
| 30 Dec 2025 |
8-K: Other Events
As previously reported, Doximity, Inc. (“Doximity” or the “Company”) and certain company directors and officers have been named as defendants in a securities litigation lawsuit (“Securities Litigation”) pending in the United States Distr... |
| 06 Nov 2025 |
8-K: Results of Operations and Financial Condition
SAN FRANCISCO, Calif., November 6, 2025 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, 2025. |
| 02 Sep 2025 |
8-K: Submission of Matters to a Vote of Security Holders
On August 28, 2025, Doximity, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the three proposals outlined in the Company’s definitive p... |
| 15 Aug 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On August 13, 2025, Doximity determined that Jennifer Chaloemtiarana, its General Counsel, Corporate Secretary, and Chief Compliance Officer, will step down from those roles effective August 29, 2025. John Vaughan will assume all three p... |
| 07 Aug 2025 |
8-K: Results of Operations and Financial Condition
SAN FRANCISCO, Calif., August 7, 2025 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. |
| 13 Jun 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
After 15 wonderful years, our co-founder, partner, and pyramid topper (!), Dr. Nate Gross is moving on. He’ll remain an advisor here at Doximity, but not in a day-to-day role. We will miss him. |
| 15 May 2025 |
8-K: Results of Operations and Financial Condition
Q4 operating cash flow of $98.5 million, up 54% year-over-year |
| 06 Feb 2025 |
8-K: Results of Operations and Financial Condition
Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year |
| 07 Nov 2024 |
8-K: Results of Operations and Financial Condition
Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year |
| 30 Aug 2024 |
8-K: Submission of Matters to a Vote of Security Holders
On August 29, 2024, Doximity, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the three proposals outlined in the Company’s definitive p... |
| 08 Aug 2024 |
8-K: Results of Operations and Financial Condition
Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year |
| 16 May 2024 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Fiscal year 2024 total revenues of $475.4 million, up 13% year-over-year |
| 08 Feb 2024 |
8-K: Results of Operations and Financial Condition
Net income growth of 43% and adjusted EBITDA growth of 32% year-over-year |
| 09 Nov 2023 |
8-K: Results of Operations and Financial Condition
Net income growth of 16% and adjusted EBITDA growth of 18% year-over-year |
Loading...